We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

PSNL Personalis Inc

-0.05 (-3.88%)
Sep 22 2023 - Closed
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Company Name Stock Ticker Symbol Market Type
Personalis Inc PSNL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -3.88% 1.24 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.28 1.24 1.32 1.24 1.29
more quote information »

Recent News

Date Time Source Heading
8/29/202316:01BWPersonalis to Present at the 21st Annual Morgan Stanley..
8/28/202317:11EDGAR2Form 8-K - Current report
8/24/202319:01BWPersonalis Announces Inducement Grants Under Nasdaq Listing..
8/08/202316:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202316:01EDGAR2Form 8-K - Current report
8/08/202316:01BWPersonalis Reports Second Quarter 2023 Financial Results
8/02/202316:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/01/202316:01BWPersonalis to Participate at Upcoming Investor Conferences
7/25/202316:01BWPersonalis to Announce Second Quarter 2023 Financial Results
6/26/202317:00BWPersonalis Files Second Patent Infringement Suit Against..
6/13/202319:01BWDr. Kenneth J. Widder Joins Personalis Board of Directors
5/30/202308:00BWPersonalis Announces Two Abstracts Accepted for Presentation..
5/16/202308:00BWPersonalis, National Cancer Center Hospital East, and Ono..
5/03/202316:01BWPersonalis Reports First Quarter 2023 Financial Results
5/02/202308:00BWPersonalis, ABRCC, and Criterium Announce Major Prospective..
4/19/202316:01BWPersonalis to Announce First Quarter 2023 Financial Results
4/05/202316:01BWPersonalis to Participate at the 22nd Annual Needham Virtual..
4/05/202308:45BWPersonalis Joins Top UK Cancer Research Organizations to..
3/22/202308:55BWPersonalis Announces Four Abstracts Accepted for..
3/07/202308:55BWPersonalis Selected for Clinical Research After Successful..
3/02/202316:05BWPersonalis Appoints Christopher Hall as Chief Executive..
2/23/202316:01BWPersonalis Reports Fourth Quarter and Full Year 2022..
2/09/202316:01BWPersonalis to Announce Fourth Quarter and Full Year 2022..
2/06/202316:01BWPersonalis to Participate at Upcoming Investor Conferences
2/03/202308:45BWPersonalis and Moderna Sign New Agreement to Leverage NeXT..
1/04/202316:01BWPersonalis Reports Preliminary Fourth Quarter and Full Year..
12/16/202216:05BWPersonalis Announces Inducement Grants Under Nasdaq Listing..
12/14/202216:02BWPersonalis Announces CEO Retirement and Transition
11/30/202208:55BWPersonalis and UCSF to Study Clinical Utility of ctDNA for..
11/21/202216:01BWPersonalis to Present at the 34th Annual Piper Sandler..
11/07/202216:05BWPersonalis Presents Data from New Platform Features at the..
11/04/202212:45TRMNMorgan Stanley Keeps Their Hold Rating on Personalis (PSNL)
11/04/202201:45TRMNBTIG Sticks to Their Buy Rating for Personalis (PSNL)
11/03/202206:30TRMNAnalysts Offer Insights on Healthcare Companies: Matinas..
11/03/202205:15TRMNNeedham Remains a Hold on Personalis (PSNL)
11/02/202216:01BWPersonalis Reports Third Quarter 2022 Financial Results
10/31/202216:16BWPersonalis Grows Leadership Team with Appointment of..
10/19/202216:01BWPersonalis to Announce Third Quarter 2022 Financial Results
10/04/202209:00BWPersonalis Forms Research Collaboration to Better Predict..
10/03/202210:25TRMNNeedham Sticks to Its Hold Rating for Personalis (PSNL)
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: D: 20230923 00:23:00